← Browse by Condition
Medical Condition
idiopathic pulmonary fibrosis
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3, Phase 1, EARLY_Phase 1
NCT06125327 Phase 2, Phase 3
Recruiting
SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
210 pts
Location
China
Sponsor
Guangzhou JOYO Pharma Co., Ltd
NCT07312305
Recruiting
Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)
Enrollment
100 pts
Location
Italy
Sponsor
University of Milan
NCT07225296 Phase 1
Recruiting
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants
Enrollment
72 pts
Location
United States
Sponsor
Genosco Inc.
NCT06853145 EARLY_Phase 1
Recruiting
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
Enrollment
6 pts
Location
United States
Sponsor
University of Virginia
NCT03800017
Recruiting
Skeletal Muscle Function in Interstitial Lung Disease
Enrollment
40 pts
Location
Canada
Sponsor
University of British Columbia